UBS is engineering a $500 million securitization of stakes in eight private credit funds, a move that highlights the growing pressure on asset managers to unlock capital in a sluggish exit environment. The deal, structured by its Unified Global Alternatives arm, hinges on a $375 million insurance wrap to protect against potential losses. This credit enhancement was crucial in securing an A2 investment-grade rating from Moody’s, making the securities palatable to a broader investor base constrained by rating requirements.
The transaction underscores a broader industry shift. With holding periods for private equity assets stretching longer and distributions from private credit strategies slowing, managers are seeking creative solutions to meet investor liquidity needs. UBS’s approach, repackaging evergreen fund interests into tradable debt, exemplifies the trend toward secured fund structures gaining traction.
Amid these strategic maneuvers, Deutsche Bank Research has reaffirmed its buy rating on UBS stock with a price target of 39 Swiss francs. Analyst Benjamin Goy acknowledges an attractive valuation but points to a rebalancing act within the bank’s operations. His stable earnings per share estimates mask opposing forces: he has trimmed forecasts for the Global Wealth Management unit while raising expectations for the Investment Banking division.
This recalibration follows UBS’s own adjusted market outlook. In early April, the bank lowered its year-end 2026 target for the S&P 500 to 7,500 points from 7,700, citing sustained higher oil prices due to Middle East conflicts. The bank believes these pressures could dampen growth and delay interest rate cuts from the Federal Reserve. Despite this, UBS maintains its S&P 500 earnings per share forecast of $310, anticipating that solid profit growth, supportive Fed policy, and AI monetization will drive markets once geopolitical effects subside.
Should investors sell immediately? Or is it worth buying UBS?
Operationally, the integration of Credit Suisse remains a core focus. Approximately 85% of Swiss client accounts have been migrated, and cumulative gross cost savings have reached $10.7 billion. The total synergy target from the acquisition was recently raised to $13.5 billion.
The coming weeks are pivotal for the Swiss banking giant. Analysts expect greater regulatory clarity on Switzerland’s “Too Big To Fail” reforms in April, a key post-acquisition consideration. More immediately, the bank will report its first-quarter 2026 results on April 29. These figures will provide a critical check on its operational health.
For the full year 2026, management is targeting a return on CET1 capital (RoCET1) of around 15% as a year-end exit rate, with an ambition to lift that target to 18% by 2028. The bank’s financial foundation appears solid, with a net profit of $7.8 billion for the past fiscal year funding an increased cash dividend of $1.10 per share.
Currently trading around €35.40, UBS shares hover just above their 50-day moving average but remain down nearly 12% year-to-date. The market’s judgment on whether the stock can recover this loss will likely hinge on the upcoming earnings report and visible progress on its strategic integration and liquidity initiatives.
Ad
UBS Stock: Buy or Sell?! New UBS Analysis from April 10 delivers the answer:
The latest UBS figures speak for themselves: Urgent action needed for UBS investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from April 10.
UBS: Buy or sell? Read more here...
